Skip to main content

This job has expired

You will need to login before you can apply for a job.

Staff Scientist, IVD/CDx Development

Employer
GRAIL, LLC
Location
Menlo Park, CA
Start date
Sep 30, 2021

View more

Discipline
Science/R&D, Biotechnology
Required Education
Doctorate/PHD/MD
Position Type
Full time
Hotbed
Biotech Bay

Job Details

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom. GRAIL, LLC is a wholly-owned subsidiary of Illumina, Inc. (NASDAQ:ILMN). For more information, please visit www.grail.com.

GRAIL is seeking a Staff Scientist for the R&D IVD product development team to contribute to the development, optimization and validation of assays for post diagnostic cancer analysis. The successful candidate will be responsible for the planning and execution of experiments and data analysis with the mentorship of senior team members. The ideal candidate is a meticulous, strong teammate with experience in nucleic acid assay development, next generation sequencing and data analysis. Experience working on regulated products and under design control is important. This position will include a mixture of lab work (~25%) and desk work (~75%). Experience with IVD/CDx development will be a plus for this role. 
You will:
  • Develop experiment plans to support study objectives
  • Test and optimize custom protocols
  • Successfully complete R&D experiments to generate high quality data
  • Document experimental details and results and perform preliminary data analysis
  • Present data in technical meetings and write study protocols and reports
  • Ensure laboratory activities are performed in compliance with best practices for assay and instrument operation, safety, and result documentation

Your qualifications and background will include:
  • M.S. or Ph.D. degree in Molecular Biology, Biochemistry, or relevant subject areas
  • Minimum 8 years of industry or equivalent work experience
  • Minimum 5 years of experience with NGS workflows
  • Expert with molecular biology laboratory techniques
  • Experience working under GLP and GDP
  • Experience with statistical programming and software (e.g., R, JMP, Python) a plus
  • Experience with IVD/CDx development will be a plus for this role. 
  • Attention to detail and safety is important
  • Strong verbal and written communication skills and willingness to collaborate cross-functionally in a fast paced and dynamic environment
  • Tolerance for change and willingness to find solutions

GRAIL is an Equal Employment Office and Affirmative Action Employer and does not discriminate on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability or any other legally protected status. We will reasonably accommodate all individuals with disabilities so that they can participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.

Following extensive monitoring, research, consideration of business implications, and advice from internal and external experts, GRAIL has made the decision to require all U.S. employees receive the COVID-19 vaccines as a condition of employment. “Full vaccination” is defined as two weeks after both doses of a two-dose vaccine or two weeks since a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request a reasonable accommodation.

GRAIL, Inc. and its affiliates and subsidiaries ("GRAIL") does not accept any liability for fees for resumes from recruiters or employment agencies (“Agency”), without a binding, written recruitment agreement between GRAIL and Agency describing the services and specific job openings (“Agreement”).  GRAIL may consider any candidate for whom an Agency has submitted an unsolicited resume and explicitly reserves the right to hire those candidate(s) without any financial obligation to the Agency, unless an Agreement is in place.  Any email or verbal contacts with any person within GRAIL is inadequate to create a binding agreement.   Agencies without an Agreement are requested not to contact any hiring managers of GRAIL with recruiting inquiries or resumes.  Agencies interested in partnering with GRAIL may contact GRAIL's HR Department through our Customer Service team.

Company

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. For more information, please visit www.grail.com.

LEADERSHIP:

CEO: Bob Ragusa

FacebookTwitter

Company info
Website
Phone
833-694-2553
Location
1525 O'Brien Drive
Menlo Park
California
94025
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert